Atara Biotherapeutics ATRA Declines 697 Support Test Looms as Biotech Sentiment Softens Rising AI Costs Lead Corporate America to Ration Usage WSJ Reports Boston Omaha Q4 2025 Earnings Significant EPS Disappointment Amid Elevated Costs Anthropic Expands European Footprint with Milan Office Plans Hiring Surge